Early Phase 1 ADD Clinical Trials
10 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–10 of 10 trials
Recruiting
Early Phase 1
Concomitant Renal and Urinary Bladder Allograft Transplantation
Chronic Kidney DiseasesBladder DysfunctionNeurogenic Bladder+6 more
Mayo Clinic30 enrolled2 locationsNCT04626167
Recruiting
Early Phase 1
Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma
Gallbladder Adenocarcinoma
West Virginia University10 enrolled1 locationNCT05430035
Recruiting
Early Phase 1
Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder
Nicotine AddictionCraving
University of California, San Diego200 enrolled1 locationNCT06582888
Recruiting
Early Phase 1
Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation
Spinal Cord Injuries (SCI)Neurogenic BladderUrinary Tract Infection (Diagnosis)
Medstar Health Research Institute40 enrolled1 locationNCT07308808
Recruiting
Early Phase 1
PET-imaging of Two Vartumabs in Patients With Solid Tumors
Breast CancerBladder CarcinomaEsophageal Carcinoma+11 more
Var2 Pharmaceuticals32 enrolled1 locationNCT06645808
Recruiting
Early Phase 1
Virtual Histology of the Bladder Wall for Bladder Cancer Staging
Urinary Bladder Neoplasms
Jodi Maranchie42 enrolled1 locationNCT04369560
Recruiting
Early Phase 1
Prophylactic Antibiotics in Cystectomy With Diversion
Muscle-Invasive Bladder CarcinomaRadical CystectomyIleal Conduit+1 more
University of Minnesota120 enrolled1 locationNCT06190197
Recruiting
Early Phase 1
Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis
Interstitial CystitisBladder Pain SyndromeChronic Interstitial Cystitis
Wake Forest University Health Sciences30 enrolled1 locationNCT04734106
Not Yet Recruiting
Early Phase 1
SUBDUE-3: A Phase 0 study of SUB-urothelial DUrvalumab-Zirconium to investigate local and systemic distribution of Durvalumab when injected in the sub-urothelium in adult subjects with muscle invasive bladder cancer or high-risk non-muscle invasive bladder tumours.
Muscle invasive or high risk non muscle invasive bladder cancer
South Metropolitan Health Service, Fiona Stanley Hospital, 11 Robin Warren Drive, MURDOCH WA 61503 enrolled1 locationACTRN12624001245583
Recruiting
Early Phase 1
Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease
Overactive BladderParkinson's DiseaseOnabotulinumtoxin A
Zhujiang Hospital60 enrolled1 locationNCT05997043